Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 23 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Intuitive Surgical is a strong buy with a positive outlook due to its dominance in the soft-tissue robotics market, potential for long-term growth, underpenetrated market opportunity, and impressive recent financial performance with Q2 revenues of $2.89 billion (+18.5% y/y) and adj. GM of 70.0%. The company has also launched new products and has a strong pipeline of potential future offerings. Risks to our positive outlook include competition, procedural and capital purchasing challenges, and changes in government policies, but overall, we believe ISRG's fundamentals remain strong and its premium valuation is justified.

Bears say

Intuitive Surgical is currently facing a slowing US procedure growth rate, impacted by factors such as the Affordable Care Act and the "law of large numbers". Despite management's prudent investment in innovation, such as the extended-use-program, which may lead to procedure growth re-acceleration in the long-term, these investments could also limit and pressure margins. Competition in the robotics surgery market, along with potential risks such as disruptions from COVID-19, slower new product adoption, and delays in new product approvals, could also impact the company's growth potential. While Intuitive Surgical remains a dominant player in the market, the deterioration of its premium valuation and uncertainty in its outlook warrant a negative outlook from a financial analyst.

Intuitive Surgical (ISRG) has been analyzed by 23 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 23 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $536.61, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $536.61, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.